Jonathan E. Levitt, Esq., co-founded the boutique healthcare law firm of Frier Levitt, LLC in 2000. Frier Levitt has a national presence in pharmacy law and has been counsel to multiple nationwide class actions of pharmacies. After graduating from Rutgers College, Rutgers University, Jonathan pursued a Juris Doctorate degree from New York Law School, where he edited the New York Law School Law Review and graduated cum laude.
At Frier Levitt, Jonathan has dedicated his practice to representing pharmacies nationally against the abusive audit practices of Pharmacy Benefit Managers (PBMs). Jonathan is the author of the LinkedIn Group “Hot Topics in Pharmacy Law.” Jonathan has an established track record of challenging PBMs and speaks at pharmacy conventions across the country in an effort to share his firm’s specialized knowledge. In addition to lecturing, Jonathan has been published in internationally-circulated publications and commits himself to pro bono and public service assignments.
For the last 11 years, Jonathan’s peers have elected him as a Super Lawyer. Jonathan is Certified by the Supreme Court of New Jersey as a Civil Trial Attorney. Jonathan has competed in triathlons, including the 2012 New York Ironman U.S. Championships, as well as Brazilian Jiu Jitsu.
In March 2017, Jonathan presented “Challenging Abusive PBM Policies: A Case Study Into PBM Treatment of ‘Physician Dispensing’ and DIR Fees” for the National Community Oncology Dispensing Association (NCODA) 2017 Forum.
In February 2017, Jonathan presented “Legal Considerations for Chain Pharmacies in the Changing Reimbursement Landscape” at the National Association of Chain Drug Stores (NACDS) Regional Chain Conference.
In January 2017, Jonathan presented “Legal and Business Considerations for Human Resources When Addressing Pharmacy Benefits” at the Marcus Evans Employer Benefits Conference.
In 2017, Jonathan presented a webinar regarding “DIR Fees: What Are They and What Can Specialty Pharmacies Do About Them” in conjunction with National Association of Specialty Pharmacy (NASP).
In October 2016, Jonathan presented “Is PBM Power Limitless? A Look at Recent PBM conduct: CVS Physician Dispensing Guidance, ESI on Oral Oncolytic Exclusivity, and DIR Fees” at the 2016 NCODA Annual Symposium.
In 2016, Jonathan presented webinars in partnership with Mediware, including, “Medicare Part D: DIR Fees and ‘Preferred Cost Sharing Networks,” “Utilizing the Federal ‘Any Willing Provider’ Law to Access Medicare Part D Networks,” and
“Governmental Investigations of Pharmacies and PBM Audits – The Rise in Medicaid Investigations and Changing PBM Audits.”